These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 24062746)

  • 1. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.
    Pastorelli L; De Salvo C; Mercado JR; Vecchi M; Pizarro TT
    Front Immunol; 2013 Sep; 4():280. PubMed ID: 24062746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.
    Jergens AE; Parvinroo S; Kopper J; Wannemuehler MJ
    Front Med (Lausanne); 2021; 8():669913. PubMed ID: 34513862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal barrier dysfunction in inflammatory bowel diseases.
    McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
    Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient mice.
    Sydora BC; Tavernini MM; Doyle J; Fedorak RN
    Inflamm Bowel Dis; 2006 Aug; 12(8):750-7. PubMed ID: 16917231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and regulation of IL-22-mediated intestinal epithelial homeostasis and repair.
    Patnaude L; Mayo M; Mario R; Wu X; Knight H; Creamer K; Wilson S; Pivorunas V; Karman J; Phillips L; Dunstan R; Kamath RV; McRae B; Terrillon S
    Life Sci; 2021 Apr; 271():119195. PubMed ID: 33581125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
    Michielan A; D'Incà R
    Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
    Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
    Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier.
    Barbara G; Barbaro MR; Fuschi D; Palombo M; Falangone F; Cremon C; Marasco G; Stanghellini V
    Front Nutr; 2021; 8():718356. PubMed ID: 34589512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D signaling in intestinal innate immunity and homeostasis.
    Dimitrov V; White JH
    Mol Cell Endocrinol; 2017 Sep; 453():68-78. PubMed ID: 28412519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
    Schlegel N; Boerner K; Waschke J
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Gut-Associated Natural Killer Cells in Health and Disease.
    Poggi A; Benelli R; Venè R; Costa D; Ferrari N; Tosetti F; Zocchi MR
    Front Immunol; 2019; 10():961. PubMed ID: 31130953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of intestinal homeostasis by mucosal barriers.
    Okumura R; Takeda K
    Inflamm Regen; 2018; 38():5. PubMed ID: 29619131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.